Posts Tagged ‘FDA’

Targeting Obesity: Win Some, Lose Some

July 22, 2016 — Targeting obesity with new treatments presents remarkable challenges. For evidence of this harsh reality, look at the sharply contrasting news this week for two potential new drugs: beloranib and setmelanotide. All work on beloranib was canceled by its developer, Zafgen. Almost simultaneously, Rhythm Pharmaceuticals published breakthrough results in the New England Journal of Medicine (NEJM) […]

Once-Daily Lorcaserin Approved. Now What?

July 21, 2016 — Eisai and Arena Pharmaceuticals announced this week that they received final approval from FDA for once-daily lorcaserin, which will be sold as Belviq XR for long-term obesity treatment. The real question is: what will this mean for the product, the patients who can benefit from it, and for obesity care more broadly? This approval will […]

Searching for Healthy Food

July 10, 2016 — Americans are searching for healthy food. The FDA is working on its guidelines for what foods can claim to be “healthy” since it had to backtrack with the makers of Kind Bars. Delving into this issue, the New York Times reports some significant gaps between what nutrition experts think is healthy and what the public thinks. Number […]

Obesity Drain Device Approved by FDA

June 16, 2016 — FDA has just approved a new gastric drain device for the treatment of severe obesity and it’s easy to find people with strong opinions about it. The AspireAssist system consists of a small tube placed through the skin and into the stomach. It connects to a port on the surface of the skin outside the […]

New Nutrition Facts Label, Now Final, Targets Sugar

May 21, 2016 — At the PHA Summit yesterday, First Lady Michelle Obama announced that the new nutrition facts label is now final, putting added sugar in the crosshairs for consumers who are paying attention. FDA notes eight changes to the label, but the real action has been focused on sugar all along. Companies have up to three years to make […]

Will FDA Save Us from Unhealthy and Unnatural Food?

May 13, 2016 — If you want a glimpse of how people feel about natural and unnatural food, just browse through many thousands of comments that FDA recently received on the matter. And this is just a prelude. The agency hasn’t proposed any rules yet. It hasn’t even decided if it will. FDA just asked for comments on putting the word “natural” on food […]

Give Me the All-Natural Fat, Sugar, and Salt

April 24, 2016 — Diet soda? No thanks. Slow-churned, low-fat ice cream? Give us the full-fat stuff. Bacon? Please. Himalayan pink sea salt? Sprinkle generously. More and more, American consumers are looking for all-natural fat, sugar, and salt in their foods. No more diet factory food for us. Edy’s Grand full fat ice cream is up 10%, while their […]

A Scorecard for Food Labeling

April 20, 2016 — Is food labeling “a surprising failure” as Omri Ben-Shahar suggests in Forbes this week? Or is the truth of food labeling that “knowledge is power,” as Emma Axelrod suggests in the Brown Political Review? The strongest example of a failure for food labeling that Ben-Shahar cites is the case study of restaurant menu labeling. The […]

Contrave Goes Back to Orexigen

March 16, 2016 — Contrave, a combination of bupropion and naltrexone, will be going back to Orexigen, which is the small biotech company that developed it as a treatment for obesity. Takeda, which launched the drug less than two years ago under a licensing agreement with Orexigen, announced Tuesday that it had decided to give up the marketing rights for Contrave in the […]

Liraglutide CV Outcomes: A Milestone for Diabetes and Obesity

March 7, 2016 — A major new study shows that people treated with liraglutide for type 2 diabetes have fewer strokes, heart attacks, and deaths from heart disease. Six years ago, cardiovascular outcomes had doctors scratching their heads about diabetes and obesity drugs. A hearing on a flawed outcome study with sibutramine resulted in its withdrawal from the market. […]